Ascendis Pharma A (ASND) Current Taxes (2012 - 2026)
Ascendis Pharma A (ASND) reported Current Taxes of $9.1 million for Q1 2026, up 452.25% on a YoY basis from $1.7 million in Q1 2025, and up 22.14% sequentially from $7.5 million in Q4 2025.
Ascendis Pharma A (ASND) Current Taxes (2012 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of Current Taxes data on file, last reported at $9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 452.25% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 452.25% YoY), and the FY2025 full-year result was $7.5 million, up 465.64% from the prior year.
- Current Taxes rose to $9.1 million in Q1 2026, from $7.5 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $9.1 million in Q1 2026 to a low of $96035.1 in Q2 2022.
- A 5-year average of $3.4 million and a median of $1.9 million in 2025 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes jumped 6445.9% in 2023 and tumbled 84.18% in 2024, its largest moves.
- Tracing ASND's Current Taxes over 5 years: stood at $5.6 million in 2022, then sank by 55.84% to $2.5 million in 2023, then slumped by 47.21% to $1.3 million in 2024, then jumped by 472.92% to $7.5 million in 2025, then advanced by 22.14% to $9.1 million in 2026.
- Business Quant data shows ASND's Current Taxes at $9.1 million in Q1 2026, $7.5 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 9.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.14 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 804,823.34 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 7.38 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 127,042.57 |
| Jun 30, 2022 | 96,035.10 |
| Mar 31, 2022 | 560,046.52 |
| Dec 31, 2021 | 226,506.25 |
| Sep 30, 2021 | 590,822.95 |
| Jun 30, 2021 | 454,010.33 |